Chest Drain Insertion Assisted by Virtual Reality
Launched by CENTRAL HOSPITAL, NANCY, FRANCE · Sep 6, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a virtual reality (VR) headset can help patients feel less pain and anxiety during a procedure called chest drain insertion. This procedure is needed for conditions like spontaneous pneumothorax (a collapsed lung) and pleural effusion (fluid buildup in the chest). The goal is to see if using VR as a distraction makes the experience more comfortable for patients.
To participate in this study, you need to be at least 18 years old and have a medical reason for needing a chest drain. You also need to be part of the French health system and be able to give clear consent to join the study. However, certain individuals won't be eligible, such as those with severe heart conditions, significant mental health issues, or those currently under the influence of alcohol or drugs. If you join, you can expect to wear a VR headset during the procedure, helping to take your mind off the discomfort. The trial is currently not recruiting participants, but it's an exciting opportunity to explore new ways to improve patient care in this area.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Indication of chest drain insertion for pleural effusion or primary spontaneous pneumothorax
- • Patient who received clear and loyal information abotu the study protocol
- • Patient who consented to participate to the study
- • Patient aged 18 years old or older
- • Patient affiliated to the french health system
- Exclusion Criteria:
- • Patient aged less than 18 years old
- • Patient in emergency situation
- • Patient with severe heart condition
- • Patient allergic to silicone
- • Patient with severe psychiatric or mental disorder
- • patient with binocular vision anomaly
- • patient with pacemaker or defibrillator
- • patient wearing a hearing aid that cannot be removed
- • Patients under the influence of alcohol or drugs, nausea, fatigue, emotional or anxiety disorders, migraine, headaches, infectious disease
- • Patient with past medical history of epilepsia or convulsion
- -- Persons covered by articles L. 1121-5 and L1121-8 of the French Public Health Code:
- • Pregnant, parturient or breast-feeding women,
- • Persons of full age subject to a legal protection measure (guardianship, curatorship, safeguard of justice)
- • adults unable to give their consent
- • Persons deprived of their liberty by a judicial or administrative decision, persons under psychiatric care under articles L. 3212-1 and L. 3213-1.
- • Person able to give consent but unable to write
- • Person able to give consent but unable to read French
- • Patient unable to consent to the study
About Central Hospital, Nancy, France
Central Hospital, located in Nancy, France, is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes. As a prominent clinical trial sponsor, the hospital is committed to conducting innovative studies across various therapeutic areas, fostering collaboration among multidisciplinary teams of healthcare professionals and researchers. With a strong emphasis on ethical standards and patient safety, Central Hospital leverages its state-of-the-art facilities and expertise to contribute to the development of cutting-edge treatments and enhance the overall quality of care within the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported